Novartis | NVS - Capitalisation Boursière

Prix De L'Action
148.11
Variation Quotidienne
-0.05 -0.03%
Mensuellement
-10.07%
Annuel
32.08%
Q1 Prévisions
142.44




Capitalisation Boursière Changement Date
AbbVie USD 403.83B 5.2B 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
Bausch Health Companies USD 2.58B 194.9M 2025-12
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Canopy Growth CAD 125.74M 530.72M 2026-03
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Glaxosmithkline GBP 107.89B 7.96B 2026-03
J&J USD 500.24B 67.44B 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 240.48B 51.73B 2026-03
Novartis USD 303.66B 40.58B 2026-03
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.4B 520M 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Phibro Animal Health USD 2B 490M 2026-03
Prestige Brands USD 2.97B 105M 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sanofi EUR 117.34B 2.45B 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
Zoetis USD 55.45B 9.4B 2025-12